If you're living with diabetes, you're probably aware of its effects on your blood sugar and general health. But did you know ...

The Food and Drug Administration (FDA) has approved Susvimo ® (ranibizumab injection) for the treatment of patients with diabetic retinopathy who have previously responded to at least 2 intravitreal ...

Lake Oswego, Oregon – As advancements in laser eye surgery continue to expand access to vision correction, individuals with ...

Researchers have identified in a new study that tight blood sugar control within a period of one year did not have a notable ...

Thanks to advancements in early detection and treatment options, it's possible to live a long and healthy life after being ...

Genentech's ranibizumab injection (Susvimo) has received FDA approval for the treatment of diabetic retinopathy. The ...

An initial trial suggests lamivudine, an inexpensive oral drug for treating HIV, can improve vision in patients with diabetic ...

At ARVO 2025, in Salt Lake City, Utah, Emma Lessieru, MD, PhD, talked about her poster on retina extracellular vesicles, and the role that they play on diabetic retinopathy.

Susvimo is the first and only FDA-approved, continuous delivery treatment shown to maintain vision in people with DR with ...

The FDA has approved Roche’s Susvimo (ranibizumab injection) 100 mg/mL for treating patients with diabetic retinopathy (DR).